|
1
|
Chaffer CL and Weinberg RA: A perspective
on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
El-Serag HB and Kanwal F: Epidemiology of
hepatocellular carcinoma in the United States: Where are we? Where
do we go? Hepatology. 60:1767–1775. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bruix J and Sherman M; American
Association for the Study of Liver Diseases: Management of
hepatocellular carcinoma: An update. Hepatology. 53:1020–1022.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Josic D, Clifton JG, Kovac S and Hixson
DC: Membrane proteins as diagnostic biomarkers and targets for new
therapies. Curr Opin Mol Ther. 10:116–123. 2008.PubMed/NCBI
|
|
7
|
Boonstra MC, de Geus SW, Prevoo HA,
Hawinkels LJ, van de Velde CJ, Kuppen PJ, Vahrmeijer AL and Sier
CF: Selecting targets for tumor imaging: An overview of
cancer-associated membrane proteins. Biomark Cancer. 8:119–133.
2016.PubMed/NCBI
|
|
8
|
Mamede AC, Laranjo M, Carvalho MJ,
Abrantes AM, Pires AS, Brito AF, Moura P, Maia CJ and Botelho MF:
Effect of amniotic membrane proteins in human cancer cell lines: An
exploratory study. J Membr Biol. 247:357–360. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rucevic M, Hixson D and Josic D: Mammalian
plasma membrane proteins as potential biomarkers and drug targets.
Electrophoresis. 32:1549–1564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li SY, Yu B, An P, Liang ZJ, Yuan SJ and
Cai HY: Effects of cell membrane phospholipid level and protein
kinase C isoenzyme expression on hepatic metastasis of colorectal
carcinoma. Hepatobiliary Pancreat Dis Int. 3:411–416.
2004.PubMed/NCBI
|
|
11
|
Sun GG, Wang YD, Cui DW, Cheng YJ and Hu
WN: Epithelial membrane protein 1 negatively regulates cell growth
and metastasis in colorectal carcinoma. World J Gastroenterol.
20:4001–4010. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Agarwal AK, Srinivasan N, Godbole R, More
SK, Budnar S, Gude RP and Kalraiya RD: Role of tumor cell surface
lysosome-associated membrane protein-1 (LAMP1) and its associated
carbohydrates in lung metastasis. J Cancer Res Clin Oncol.
141:1563–1574. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee TY, Chang HH, Kuo JJ and Shen JJ:
Changes of hepatic proteome in bile duct ligated rats with hepatic
fibrosis following treatment with Yin-Chen-Hao-Tang. Int J Mol Med.
23:477–484. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ross PL, Huang YN, Marchese JN, Williamson
B, Parker K, Hattan S, Khainovski N, Pillai S, Dey S, Daniels S, et
al: Multiplexed protein quantitation in Saccharomyces cerevisiae
using amine-reactive isobaric tagging reagents. Mol Cell
Proteomics. 3:1154–1169. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li Y, Tang ZY, Ye SL, Liu YK, Chen J, Xue
Q, Chen J, Gao DM and Bao WH: Establishment of cell clones with
different metastatic potential from the metastatic hepatocellular
carcinoma cell line MHCC97. World J Gastroenterol. 7:630–636. 2001.
View Article : Google Scholar
|
|
16
|
Wang C, Zhu ZM, Liu CL, He XJ, Zhang HY
and Dong JH: Knockdown of yes-associated protein inhibits
proliferation and downregulates large tumor suppressor 1 expression
in MHCC97H human hepatocellular carcinoma cells. Mol Med Rep.
11:4101–4108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zou YH, Li XD, Zhang QH and Liu DZ: RACK1
silencing induces cell apoptosis and inhibits cell proliferation in
hepatocellular carcinoma MHCC97-H cells. Pathol Oncol Res.
24:101–107. 2018. View Article : Google Scholar
|
|
18
|
Tian M, Cheng H, Wang Z, Su N, Liu Z, Sun
C, Zhen B, Hong X, Xue Y and Xu P: Phosphoproteomic analysis of the
highly-metastatic hepatocellular carcinoma cell line, MHCC97-H. Int
J Mol Sci. 16:4209–4225. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun H and Liu GT: Inhibitory effect of
anti-hepatitis drug bicyclol on invasion of human hepatocellular
carcinoma MHCC97-H cells with high metastasis potential and its
relative mechanisms. J Asian Nat Prod Res. 11:576–583. 2009.
View Article : Google Scholar
|
|
20
|
Yang Y, Toy W, Choong LY, Hou P, Ashktorab
H, Smoot DT, Yeoh KG and Lim YP: Discovery of SLC3A2 cell membrane
protein as a potential gastric cancer biomarker: Implications in
molecular imaging. J Proteome Res. 11:5736–5747. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang LN, Tong SW, Hu HD, Ye F, Li SL, Ren
H, Zhang DZ, Xiang R and Yang YX: Quantitative proteome analysis of
ovarian cancer tissues using a iTRAQ approach. J Cell Biochem.
113:3762–3772. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
She S, Xiang Y, Yang M, Ding X, Liu X, Ma
L, Liu Q, Liu B, Lu Z, Li S, et al: C-reactive protein is a
biomarker of AFP-negative HBV-related hepatocellular carcinoma. Int
J Oncol. 47:543–554. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-ΔΔC(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
24
|
Bledi Y, Inberg A and Linial M: PROCEED: A
proteomic method for analysing plasma membrane proteins in living
mammalian cells. Brief Funct Genomics Proteomics. 2:254–265. 2003.
View Article : Google Scholar
|
|
25
|
Josic D and Clifton JG: Mammalian plasma
membrane proteomics. Proteomics. 7:3010–3029. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang H, Tian B, Yu H, Yao H and Gao Z:
LAPTM4B-35 protein as a potential therapeutic target in gastric
cancer. Tumour Biol. 35:12737–12742. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yoshizaki T, Kondo S, Endo K, Nakanishi Y,
Aga M, Kobayashi E, Hirai N, Sugimoto H, Hatano M, Ueno T, et al:
Modulation of the tumor microenvironment by Epstein-Barr virus
latent membrane protein 1 in nasopharyngeal carcinoma. Cancer Sci.
109:272–278. 2018. View Article : Google Scholar
|
|
28
|
Xue Q, Zhou Y, Wan C, Lv L, Chen B, Cao X,
Ju G, Huang Y, Ni R and Mao G: Epithelial membrane protein 3 is
frequently shown as promoter methylation and functions as a tumor
suppressor gene in non-small cell lung cancer. Exp Mol Pathol.
95:313–318. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liang S, Xu Z, Xu X, Zhao X, Huang C and
Wei Y: Quantitative proteomics for cancer biomarker discovery. Comb
Chem High Throughput Screen. 15:221–231. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tian J, Tang Z and Ye S: Establishment of
a human hepatocellular carcinoma (HCC) cell line with high
metastatic potential (MHCC97) and its biological characteristics.
Zhonghua Zhong Liu Za Zhi. 20:405–407. 1998.In Chinese.
|
|
31
|
Tian J, Tang ZY, Ye SL, Liu YK, Lin ZY,
Chen J and Xue Q: New human hepatocellular carcinoma (HCC) cell
line with highly metastatic potential (MHCC97) and its expressions
of the factors associated with metastasis. Br J Cancer. 81:814–821.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen B, Wang J, Dai D, Zhou Q, Guo X, Tian
Z, Huang X, Yang L, Tang H and Xie X: AHNAK suppresses tumour
proliferation and invasion by targeting multiple pathways in
triple-negative breast cancer. J Exp Clin Cancer Res. 36:652017.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hoe SL, Tan LP, Abdul Aziz N, Liew K, Teow
SY, Abdul Razak FR, Chin YM, Mohamed Shahrehan NA, Chu TL, Mohd
Kornain NK, et al: CD24, CD44 and EpCAM enrich for
tumour-initiating cells in a newly established patient-derived
xenograft of nasopharyngeal carcinoma. Sci Rep. 7:123722017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Qin Q, Wei F, Zhang J and Li B: miR-134
suppresses the migration and invasion of non small cell lung cancer
by targeting ITGB1. Oncol Rep. 37:823–830. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yáñez-Mó M, Barreiro O, Gordon-Alonso M,
Sala-Valdés M and Sánchez-Madrid F: Tetraspanin-enriched
microdomains: A functional unit in cell plasma membranes. Trends
Cell Biol. 19:434–446. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zöller M: Tetraspanins: Push and pull in
suppressing and promoting metastasis. Nat Rev Cancer. 9:40–55.
2009. View
Article : Google Scholar
|
|
37
|
Hemler ME: Tetraspanin proteins mediate
cellular penetration, invasion, and fusion events and define a
novel type of membrane microdomain. Annu Rev Cell Dev Biol.
19:397–422. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zijlstra A, Lewis J, Degryse B, Stuhlmann
H and Quigley JP: The inhibition of tumor cell intravasation and
subsequent metastasis via regulation of in vivo tumor cell motility
by the tetraspanin CD151. Cancer Cell. 13:221–234. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Schröder HM, Hoffmann SC, Hecker M, Korff
T and Ludwig T: The tetraspanin network modulates MT1-MMP cell
surface trafficking. Int J Biochem Cell Biol. 45:1133–1144. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Boucheix C and Rubinstein E: Tetraspanins.
Cell Mol Life Sci. 58:1189–1205. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Boucheix C, Benoit P, Frachet P, Billard
M, Worthington RE, Gagnon J and Uzan G: Molecular cloning of the
CD9 antigen. A new family of cell surface proteins. J Biol Chem.
266:117–122. 1991.PubMed/NCBI
|
|
42
|
Lanza F, Wolf D, Fox CF, Kieffer N, Seyer
JM, Fried VA, Coughlin SR, Phillips DR and Jennings LK: cDNA
cloning and expression of platelet p24/CD9. Evidence for a new
family of multiple membrane-spanning proteins. J Biol Chem.
266:10638–10645. 1991.PubMed/NCBI
|
|
43
|
Maecker HT, Todd SC and Levy S: The
tetraspanin superfamily: Molecular facilitators. FASEB J.
11:428–442. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Miyake M, Nakano K, Itoi SI, Koh T and
Taki T: Motility-related protein-1 (MRP-1/CD9) reduction as a
factor of poor prognosis in breast cancer. Cancer Res.
56:1244–1249. 1996.PubMed/NCBI
|
|
45
|
Copeland BT, Bowman MJ, Boucheix C and
Ashman LK: Knockout of the tetraspanin Cd9 in the TRAMP model of de
novo prostate cancer increases spontaneous metastases in an
organ-specific manner. Int J Cancer. 133:1803–1812. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hashida H, Takabayashi A, Tokuhara T, Taki
T, Kondo K, Kohno N, Yamaoka Y and Miyake M: Integrin α3 expression
as a prognostic factor in colon cancer: Association with MRP-1/CD9
and KAI1/CD82. Int J Cancer. 97:518–525. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Higashiyama M, Taki T, Ieki Y, Adachi M,
Huang CL, Koh T, Kodama K, Doi O and Miyake M: Reduced motility
related protein-1 (MRP-1/CD9) gene expression as a factor of poor
prognosis in non-small cell lung cancer. Cancer Res. 55:6040–6044.
1995.PubMed/NCBI
|
|
48
|
Fabian J, Opitz D, Althoff K, Lodrini M,
Hero B, Volland R, Beckers A, de Preter K, Decock A, Patil N, et
al: MYCN and HDAC5 transcriptionally repress CD9 to trigger
invasion and metastasis in neuroblastoma. Oncotarget.
7:66344–66359. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Houle CD, Ding XY, Foley JF, Afshari CA,
Barrett JC and Davis BJ: Loss of expression and altered
localization of KAI1 and CD9 protein are associated with epithelial
ovarian cancer progression. Gynecol Oncol. 86:69–78. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Sauer G, Windisch J, Kurzeder C, Heilmann
V, Kreienberg R and Deissler H: Progression of cervical carcinomas
is associated with down-regulation of CD9 but strong local
re-expression at sites of transendothelial invasion. Clin Cancer
Res. 9:6426–6431. 2003.PubMed/NCBI
|
|
51
|
Wang JC, Bégin LR, Bérubé NG, Chevalier S,
Aprikian AG, Gourdeau H and Chevrette M: Down-regulation of CD9
expression during prostate carcinoma progression is associated with
CD9 mRNA modifications. Clin Cancer Res. 13:2354–2361. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Herr MJ, Kotha J, Hagedorn N, Smith B and
Jennings LK: Tetraspanin CD9 promotes the invasive phenotype of
human fibrosarcoma cells via upregulation of matrix
metalloproteinase-9. PLoS One. 8:e677662013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zheng R, Yano S, Zhang H, Nakataki E,
Tachibana I, Kawase I, Hayashi S and Sone S: CD9 overexpression
suppressed the liver metastasis and malignant ascites via
inhibition of proliferation and motility of small-cell lung cancer
cells in NK cell-depleted SCID mice. Oncol Res. 15:365–372. 2005.
View Article : Google Scholar
|
|
54
|
Uhlén M, Fagerberg L, Hallström BM,
Lindskog C, Oksvold P, Mardinoglu A, Sivertsson Å, Kampf C,
Sjöstedt E, Asplund A, et al: Proteomics. Tissue-based map of the
human proteome. Science. 347:12604192015. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Sho M, Adachi M, Taki T, Hashida H,
Konishi T, Huang CL, Ikeda N, Nakajima Y, Kanehiro H, Hisanaga M,
et al: Transmembrane 4 superfamily as a prognostic factor in
pancreatic cancer. Int J Cancer. 79:509–516. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Mori M, Mimori K, Shiraishi T, Haraguchi
M, Ueo H, Barnard GF and Akiyoshi T: Motility related protein 1
(MRP1/CD9) expression in colon cancer. Clin Cancer Res.
4:1507–1510. 1998.PubMed/NCBI
|
